Infection and transmission dynamics of rKSHV.219 in primary endothelial cells

Hannah C. Jeffery; Rachel L. Wheat; David J. Blackbourn; Gerard B. Nash; Lynn M. Butler

doi:10.1016/j.jviromet.2013.06.001

Infection and transmission dynamics of rKSHV.219 in primary endothelial cells

Hannah C. Jeffery, Rachel L. Wheat, David J. Blackbourn, Gerard B. Nash, Lynn M. Butler^*

^*Corresponding author for this work

Medical Sciences

University of Birmingham

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is the aetiologic agent of Kaposi's sarcoma (KS), a tumour of endothelial cell origin. The study of KS development was aided by the generation of a recombinant GFP (latent)/RFP (lytic)-expressing KSHV (rKSHV.219) by Vieira and O'Hearn (2004). In this study the first data characterising primary endothelial cell infection and transmission with this virus is presented. Infection was predominantly latent and the percentage of GFP-positive cells increased over time. Neither horizontal transmission of infection, nor cellular proliferation, explained this increase. Analysis of latency-associated nuclear antigen (LANA-1) expression revealed that a threshold level of infection was required for GFP expression early post infection. At later time points GFP correlated more closely with LANA-1 expression, likely due to the accumulation of GFP over time. This study provides methodological guidance for the use of rKSHV.21. In addition, it highlights potential problems associated with the use of fluorescent proteins as markers of viral infection.

Original language	English
Pages (from-to)	251-259
Number of pages	9
Journal	Journal of Virological Methods
Volume	193
Issue number	1
DOIs	https://doi.org/10.1016/j.jviromet.2013.06.001
Publication status	Published - Oct 2013

Bibliographical note

Funding Information:
This work was funded by a University of Birmingham College of Medical and Dental Sciences post-graduate research studentship (HJ), a Cancer Research UK grant ( C7934 ) to LMB, GN and DJB and grants to DJB from the Medical Research Council ( G0400408, G0800154 ). The authors acknowledge Jeff Vieira for the generous provision of rKSHV219-infected Vero cells and BacK50 baculovirus.

Keywords

Endothelial cell
Kaposi's sarcoma-associated herpes virus
Rkshv.219

Access to Document

10.1016/j.jviromet.2013.06.001

Cite this

@article{c6e7b484fcd84b6fb83ff5e88db5b516,

title = "Infection and transmission dynamics of rKSHV.219 in primary endothelial cells",

abstract = "Kaposi's sarcoma-associated herpesvirus (KSHV) is the aetiologic agent of Kaposi's sarcoma (KS), a tumour of endothelial cell origin. The study of KS development was aided by the generation of a recombinant GFP (latent)/RFP (lytic)-expressing KSHV (rKSHV.219) by Vieira and O'Hearn (2004). In this study the first data characterising primary endothelial cell infection and transmission with this virus is presented. Infection was predominantly latent and the percentage of GFP-positive cells increased over time. Neither horizontal transmission of infection, nor cellular proliferation, explained this increase. Analysis of latency-associated nuclear antigen (LANA-1) expression revealed that a threshold level of infection was required for GFP expression early post infection. At later time points GFP correlated more closely with LANA-1 expression, likely due to the accumulation of GFP over time. This study provides methodological guidance for the use of rKSHV.21. In addition, it highlights potential problems associated with the use of fluorescent proteins as markers of viral infection.",

keywords = "Endothelial cell, Kaposi's sarcoma-associated herpes virus, Rkshv.219",

author = "Jeffery, {Hannah C.} and Wheat, {Rachel L.} and Blackbourn, {David J.} and Nash, {Gerard B.} and Butler, {Lynn M.}",

note = "Funding Information: This work was funded by a University of Birmingham College of Medical and Dental Sciences post-graduate research studentship (HJ), a Cancer Research UK grant ( C7934 ) to LMB, GN and DJB and grants to DJB from the Medical Research Council ( G0400408, G0800154 ). The authors acknowledge Jeff Vieira for the generous provision of rKSHV219-infected Vero cells and BacK50 baculovirus. ",

year = "2013",

month = oct,

doi = "10.1016/j.jviromet.2013.06.001",

language = "English",

volume = "193",

pages = "251--259",

journal = "Journal of Virological Methods",

issn = "0166-0934",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Infection and transmission dynamics of rKSHV.219 in primary endothelial cells

AU - Jeffery, Hannah C.

AU - Wheat, Rachel L.

AU - Blackbourn, David J.

AU - Nash, Gerard B.

AU - Butler, Lynn M.

N1 - Funding Information: This work was funded by a University of Birmingham College of Medical and Dental Sciences post-graduate research studentship (HJ), a Cancer Research UK grant ( C7934 ) to LMB, GN and DJB and grants to DJB from the Medical Research Council ( G0400408, G0800154 ). The authors acknowledge Jeff Vieira for the generous provision of rKSHV219-infected Vero cells and BacK50 baculovirus.

PY - 2013/10

Y1 - 2013/10

N2 - Kaposi's sarcoma-associated herpesvirus (KSHV) is the aetiologic agent of Kaposi's sarcoma (KS), a tumour of endothelial cell origin. The study of KS development was aided by the generation of a recombinant GFP (latent)/RFP (lytic)-expressing KSHV (rKSHV.219) by Vieira and O'Hearn (2004). In this study the first data characterising primary endothelial cell infection and transmission with this virus is presented. Infection was predominantly latent and the percentage of GFP-positive cells increased over time. Neither horizontal transmission of infection, nor cellular proliferation, explained this increase. Analysis of latency-associated nuclear antigen (LANA-1) expression revealed that a threshold level of infection was required for GFP expression early post infection. At later time points GFP correlated more closely with LANA-1 expression, likely due to the accumulation of GFP over time. This study provides methodological guidance for the use of rKSHV.21. In addition, it highlights potential problems associated with the use of fluorescent proteins as markers of viral infection.

AB - Kaposi's sarcoma-associated herpesvirus (KSHV) is the aetiologic agent of Kaposi's sarcoma (KS), a tumour of endothelial cell origin. The study of KS development was aided by the generation of a recombinant GFP (latent)/RFP (lytic)-expressing KSHV (rKSHV.219) by Vieira and O'Hearn (2004). In this study the first data characterising primary endothelial cell infection and transmission with this virus is presented. Infection was predominantly latent and the percentage of GFP-positive cells increased over time. Neither horizontal transmission of infection, nor cellular proliferation, explained this increase. Analysis of latency-associated nuclear antigen (LANA-1) expression revealed that a threshold level of infection was required for GFP expression early post infection. At later time points GFP correlated more closely with LANA-1 expression, likely due to the accumulation of GFP over time. This study provides methodological guidance for the use of rKSHV.21. In addition, it highlights potential problems associated with the use of fluorescent proteins as markers of viral infection.

KW - Endothelial cell

KW - Kaposi's sarcoma-associated herpes virus

KW - Rkshv.219

UR - http://www.scopus.com/inward/record.url?scp=84879998566&partnerID=8YFLogxK

U2 - 10.1016/j.jviromet.2013.06.001

DO - 10.1016/j.jviromet.2013.06.001

M3 - Article

C2 - 23764419

AN - SCOPUS:84879998566

SN - 0166-0934

VL - 193

SP - 251

EP - 259

JO - Journal of Virological Methods

JF - Journal of Virological Methods

IS - 1

ER -

Infection and transmission dynamics of rKSHV.219 in primary endothelial cells

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this